company background image
1786 logo

SciVision Biotech TWSE:1786 Stock Report

Last Price

NT$127.00

Market Cap

NT$8.7b

7D

-3.1%

1Y

42.2%

Updated

04 Jul, 2024

Data

Company Financials +

1786 Stock Overview

Engages in the production and sale of hyaluronic acid medical products in Taiwan and internationally.

1786 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends3/6

SciVision Biotech Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SciVision Biotech
Historical stock prices
Current Share PriceNT$127.00
52 Week HighNT$140.50
52 Week LowNT$72.20
Beta0.61
11 Month Change8.55%
3 Month Change10.92%
1 Year Change42.22%
33 Year Change153.30%
5 Year Change98.20%
Change since IPO320.77%

Recent News & Updates

Recent updates

SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Jun 28
SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Shareholder Returns

1786TW Medical EquipmentTW Market
7D-3.1%-0.3%2.7%
1Y42.2%11.1%38.2%

Return vs Industry: 1786 exceeded the TW Medical Equipment industry which returned 11.1% over the past year.

Return vs Market: 1786 exceeded the TW Market which returned 38.2% over the past year.

Price Volatility

Is 1786's price volatile compared to industry and market?
1786 volatility
1786 Average Weekly Movement6.2%
Medical Equipment Industry Average Movement4.4%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1786's share price has been volatile over the past 3 months.

Volatility Over Time: 1786's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990n/aTai Xian Hanwww.scivision.com.tw

SciVision Biotech Inc. engages in the production and sale of hyaluronic acid medical products in Taiwan and internationally. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It is also involved in the wholesale of medical equipment; and provides management consulting services.

SciVision Biotech Inc. Fundamentals Summary

How do SciVision Biotech's earnings and revenue compare to its market cap?
1786 fundamental statistics
Market capNT$8.67b
Earnings (TTM)NT$196.83m
Revenue (TTM)NT$787.96m

44.1x

P/E Ratio

11.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1786 income statement (TTM)
RevenueNT$787.96m
Cost of RevenueNT$203.81m
Gross ProfitNT$584.15m
Other ExpensesNT$387.33m
EarningsNT$196.83m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.88
Gross Margin74.13%
Net Profit Margin24.98%
Debt/Equity Ratio19.5%

How did 1786 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

85%

Payout Ratio

Does 1786 pay a reliable dividends?

See 1786 dividend history and benchmarks
When do you need to buy 1786 by to receive an upcoming dividend?
SciVision Biotech dividend dates
Ex Dividend DateJul 24 2024
Dividend Pay DateAug 16 2024
Days until Ex dividend19 days
Days until Dividend pay date42 days

Does 1786 pay a reliable dividends?

See 1786 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.